In 2007, 66 Inspections from the Argentine Ministry of Health were conducted at Clinical Research Sites and in 2006 Argentina was the leading country in the Latin American Region for IND studies with over 458 studies approved to be conducted. FDA and ANMAT's inspections have increased in number together with Argentina being the country in the region with the highest growth rate in the Clinical Research Market. We go through the panorama from setting to background and where we are today.
CEO - Development Strategy and Quality Assurance,
Blanchad & Asociados - LATINABA